Gregg Lapointe
Chairman chez RAPTOR PHARMACEUTICAL CORP
Fortune : 111 295 $ au 31/03/2024
Profil
Gregg Anthony Lapointe is the founder of Cerium Pharmaceuticals, Inc. He currently holds the position of Chairman at Rigel Pharmaceuticals, Inc. since 2022 and at Horizon Pharmaceutical LLC since 2015.
He is also an Independent Director at Soligenix, Inc. since 2009 and at Astria Therapeutics, Inc. since 2019.
Additionally, he serves as a Director at S1 BioPharma, Inc. Furthermore, he holds positions as a Director at Cytori Therapeutics, Inc., a Member-Corporate Council at Child Neurology Foundation, and a Member-Corporate Council at Kidney Care Partners.
In his former roles, Mr. Lapointe served as the Chief Executive Officer at Essetifin SpA from 2008 to 2012 and at Leadiant Biosciences, Inc. from 2001 to 2012.
He was also an Independent Director at SciClone Pharmaceuticals LLC from 2009 to 2016.
Additionally, he served as a Director at Questcor Pharmaceuticals, Inc. from 2005 to 2007, at ImmunoCellular Therapeutics Ltd.
from 2015 to 2017, at Plus Therapeutics, Inc. from 2017 to 2020, and at Raptor Pharmaceuticals Corp.
from 2014 to 2016.
He held the position of Director at Pharmaceutical Research & Manufacturers of America from 2009 to 2012.
Furthermore, he serves as a Director at Ajinomoto Cambrooke, Inc. and The Signature Group, Inc. (Virginia).
Mr. Lapointe's education includes an MBA from Duke University, a graduate degree from McGill University, and an undergraduate degree from Concordia University.
Détentions connues dans des sociétés publiques
| Société | Date | Nombre d'actions | Valorisation | Date de valorisation |
|---|---|---|---|---|
| 26/05/2023 | 75 000 ( 0,04% ) | 111 000 $ | 31/03/2024 | |
SOLIGENIX, INC.
0,00% | 08/03/2024 | 492 ( 0,00% ) | 295 $ | 31/03/2024 |
| 02/06/2023 | 0 ( -.--% ) | - $ | 31/03/2024 |
Postes actifs de Gregg Lapointe
| Sociétés | Poste | Début |
|---|---|---|
| SOLIGENIX, INC. | Director/Board Member | 01/03/2009 |
| RAPTOR PHARMACEUTICAL CORP | Chairman | 01/08/2015 |
| RIGEL PHARMACEUTICALS, INC. | Chairman | 01/05/2022 |
| ASTRIA THERAPEUTICS, INC. | Director/Board Member | 04/01/2019 |
S1 BioPharma, Inc.
 S1 BioPharma, Inc. Pharmaceuticals: MajorHealth Technology S1 BioPharma, Inc. is a clinical stage biopharmaceutical company, which engages in the development of drugs for the treatment of sexual dysfunction in both women and men. Its product portfolio include Lorexy's, Orexa, S1B-307, and S1B-3006. The company was founded in 2008 and is headquartered in New York, NY. | Director/Board Member | 01/08/2014 |
Cerium Pharmaceuticals, Inc.
 Cerium Pharmaceuticals, Inc. BiotechnologyHealth Technology Cerium Pharmaceuticals, Inc. develops and commercializes medicines for rare and ultra-rare diseases. The company was founded by Gregg Anthony Lapointe and is headquartered in Gaithersburg, MD. | Chief Executive Officer | 01/04/2012 |
Kidney Care Partners
 Kidney Care Partners Medical/Nursing ServicesHealth Services Kidney Care Partners provides healthcare services. It specializes in patient survival, hospitalization and patient experience with care. The company was founded in May 2003 and is headquartered in Washington, DC. | Corporate Officer/Principal | - |
| Child Neurology Foundation | Corporate Officer/Principal | - |
Cytori Therapeutics, Inc.
 Cytori Therapeutics, Inc. BiotechnologyHealth Technology Cytori Therapeutics, Inc. develops treatments and devices for cell therapy. The private company is based in San Diego, CA. | Director/Board Member | - |
Anciens postes connus de Gregg Lapointe
| Sociétés | Poste | Fin |
|---|---|---|
| ░░░░ ░░░░░░░░░░░░░ ░░░░ | ░░░░░░░░░░░░░░ ░░░░░░ | ░░░░░░░░░░ |
| ░░░ ░░░░░░░░░░░░░░░ ░░░░░░░░░ ░░░░ | ░░░░░░░░░░░░░░ ░░░░░░ | ░░░░░░░░░░ |
| ░░░░░░ ░░░░░░░░░░░░░░░ ░░░░░ | ░░░░░░░░░░░░░░ ░░░░░░ | ░░░░░░░░░░ |
| ░░░░░░░░ ░░░░░░░░░░░░░░░░ ░░░░ | ░░░░░░░░░░░░░░ ░░░░░░ | ░░░░░░░░░░ |
| ░░░░░░░░░ ░░░ | ░░░░░░░░░ | ░░░░░░░░░░ |
Formation de Gregg Lapointe
| Duke University | Masters Business Admin |
| McGill University | Graduate Degree |
| Concordia University | Undergraduate Degree |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Sociétés cotées | 4 |
|---|---|
| SOLIGENIX, INC. | Health Technology |
| RIGEL PHARMACEUTICALS, INC. | Health Technology |
| ASTRIA THERAPEUTICS, INC. | Health Technology |
| PLUS THERAPEUTICS, INC. | Health Technology |
| Entreprise privées | 17 |
|---|---|
SciClone Pharmaceuticals LLC
 SciClone Pharmaceuticals LLC Pharmaceuticals: MajorHealth Technology SciClone Pharmaceuticals LLC was engaged in the development of therapeutic treatment for oncology, infectious diseases, and cardiovascular disorders. It was also offering ZADAXIN for the treatment of hepatitis B, hepatitis C, certain cancers, and used as immune system enhancer, and DC Bead which is used for the novel treatment of liver cancer. The company was founded in 1990 and was headquartered in San Mateo, CA. | Health Technology |
Essetifin SpA
 Essetifin SpA Pharmaceuticals: MajorHealth Technology Essetifin SpA operates as a holding company. The company was founded in 1957 and is headquartered in Rome, Italy. | Health Technology |
Questcor Pharmaceuticals, Inc.
 Questcor Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Questcor Pharmaceuticals, Inc. was engaged in development, marketing and sale of prescription drugs. It operated as a biopharmaceutical company which focuses on the treatment of patients with serious, difficult-to-treat autoimmune and inflammatory disorders. The company's primary product was H.P. Acthar Gel, an injectable drug for the treatment of proteinuria in the nephrotic syndrome of the idiopathic type, or NS, the treatment of acute exacerbations of multiple sclerosis, or MS, in adults, the treatment of infantile spasms, or IS, in infants and children under two years of age, and the treatment of certain rheumatology related conditions, including the treatment of the rare and closely related neuromuscular disorders dermatomyositis and polymyositis. Questcor Pharmaceuticals was founded in September 1992 and was headquartered in Anaheim, CA. | Health Technology |
ImmunoCellular Therapeutics Ltd.
 ImmunoCellular Therapeutics Ltd. BiotechnologyHealth Technology ImmunoCellular Therapeutics, Ltd. is a clinical-stage pharmaceutical company, focused on the development of therapeutics and delivery technologies for the treatment of inflammatory conditions and ocular diseases. Its lead clinical asset is EOM613 solution, a peptide nucleic-acid solution with anti-inflammatory and pro-inflammatory effects on cytokines and chemokines for the treatment of cancer cachexia and rheumatoid arthritis. The company also develops EOM 147, an investigational, broad-spectrum aminosterol with an intracellular mechanism for the treatment of chronic and debilitating retinal diseases. The company was founded on March 20, 1987 and is headquartered in Montvale, NJ. | Health Technology |
Leadiant Biosciences, Inc.
 Leadiant Biosciences, Inc. Pharmaceuticals: MajorHealth Technology Leadiant Biosciences, Inc. operates as a research-based pharmaceutical company. It develops and commercializes medicines for rare diseases. The company was founded in 1989 by Claudio Cavazza and is headquartered in Gaithersburg, MD. | Health Technology |
AstenJohnson, Inc.
 AstenJohnson, Inc. Industrial MachineryProducer Manufacturing AstenJohnson, Inc. manufactures paper machine clothing, specialty fabrics, filaments, and drainage equipment. Its products include pulp mill and paper mill. The company was founded in 1999 and is headquartered in Charleston, SC. | Producer Manufacturing |
Raptor Pharmaceuticals Corp.
 Raptor Pharmaceuticals Corp. Pharmaceuticals: MajorHealth Technology The Group's principal activity is to research and development a novel drug and drug-targeting platform intended to initially treat a variety of brain disorders, neurodegenerative diseases, cancer and metabolic diseases through the proprietary use of a natural human protein known as the receptor-associated protein (RAP). The Group is in development stage. The Group acquired Convivia, Inc in 2007. | Health Technology |
Pharmaceutical Research & Manufacturers of America
 Pharmaceutical Research & Manufacturers of America Pharmaceuticals: MajorHealth Technology Pharmaceutical Research & Manufacturers of America provides pharmaceutical research and biotechnology services. It represents the country’s biopharmaceutical research companies, which are devoted to discovering and developing medicines that enable patients to live longer, healthier, and more productive lives. The company was founded in 1958 and is headquartered Washington, DC. | Health Technology |
The National Organization for Rare Disorders, Inc.
 The National Organization for Rare Disorders, Inc. Services to the Health IndustryHealth Services The National Organization for Rare Disorders, Inc. operates as a non-profit federation of voluntary health organizations to help individuals with diseases and disorders. Its services are focused on the identification, treatment, and cure of disorders through programs of education, advocacy, research, and service. The company was founded in 1983 and is headquartered in Danbury, CT. | Health Services |
| Child Neurology Foundation | |
Kidney Care Partners
Kidney Care Partners Medical/Nursing ServicesHealth Services Kidney Care Partners provides healthcare services. It specializes in patient survival, hospitalization and patient experience with care. The company was founded in May 2003 and is headquartered in Washington, DC. | Health Services |
Ajinomoto Cambrooke, Inc.
 Ajinomoto Cambrooke, Inc. Pharmaceuticals: OtherHealth Technology Ajinomoto Cambrooke, Inc. operates as a therapeutic nutrition company. It offers Glytactin with GMP to help meet the nutritional needs of patients with Phenylketonuria; Tylactin with GMP to help meet the nutritional needs of patients with Tyrosinemia; amino acid formulas for the dietary management of disorders of amino acid metabolism; low protein food; KetoVie, ketogenic formulas for the dietary management of intractable epilepsy; and KetoVie Café Food low-carbohydrate ketogenic food for individuals following the spectrum of ketogenic diets. The company was founded by David Paolella and Lynn Paolella in 2000 and is headquartered in Ayer, MA. | Health Technology |
The Signature Group, Inc. (Virginia)
 The Signature Group, Inc. (Virginia) Miscellaneous Commercial ServicesCommercial Services The Signature Group, Inc. (Virginia) provides information technology consulting and management services. Its services are targeted towards enterprise class clients, small and medium size businesses, the telecommunication industry, associations and non-profits, as well as federal, state, and local governments. The firm provides information technology consulting, design, project management, implementation and support services. The Signature Group was founded by Rochelle Bratton and Michael C. Perdue in 1986 and is headquartered in Vienna, VA. | Commercial Services |
Horizon Pharmaceutical LLC
 Horizon Pharmaceutical LLC Pharmaceuticals: MajorHealth Technology Horizon Pharmaceutical LLC engages in the development of transformative treatments for people affected by rare and debilitating diseases. It offers PROCYSBI, a delayed-release capsule, which is used for the management of nephropathic cystinosis in adults and for six years and older children. The company was founded by Christopher M. Starr and Todd C. Zankel on April 29, 2002 and is headquartered in Novato, CA. | Health Technology |
Cerium Pharmaceuticals, Inc.
Cerium Pharmaceuticals, Inc. BiotechnologyHealth Technology Cerium Pharmaceuticals, Inc. develops and commercializes medicines for rare and ultra-rare diseases. The company was founded by Gregg Anthony Lapointe and is headquartered in Gaithersburg, MD. | Health Technology |
S1 BioPharma, Inc.
S1 BioPharma, Inc. Pharmaceuticals: MajorHealth Technology S1 BioPharma, Inc. is a clinical stage biopharmaceutical company, which engages in the development of drugs for the treatment of sexual dysfunction in both women and men. Its product portfolio include Lorexy's, Orexa, S1B-307, and S1B-3006. The company was founded in 2008 and is headquartered in New York, NY. | Health Technology |
Cytori Therapeutics, Inc.
Cytori Therapeutics, Inc. BiotechnologyHealth Technology Cytori Therapeutics, Inc. develops treatments and devices for cell therapy. The private company is based in San Diego, CA. | Health Technology |
